REVIEW 1 cited by
Model Based Reinforcement Learning for Personalized Heparin Dosing
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
A key challenge in sequential decision making is optimizing systems safely under partial information. While much of the literature has focused on the cases of either partially known states or partially known dynamics, it is further exacerbated in cases where both states and dynamics are partially known. Computing heparin doses for patients fits this paradigm since the concentration of heparin in the patient cannot be measured directly and the rates at which patients metabolize heparin vary greatly between individuals. While many proposed solutions are model free, they require complex models and have difficulty ensuring safety. However, if some of the structure of the dynamics is known, a model based approach can be leveraged to provide safe policies. In this paper we propose such a framework to address the challenge of optimizing personalized heparin doses. We use a predictive model parameterized individually by patient to predict future therapeutic effects. We then leverage this model using a scenario generation based approach that is capable of ensuring patient safety. We validate our models with numerical experiments by comparing the predictive capabilities of our model against existing machine learning techniques and demonstrating how our dosing algorithm can treat patients in a simulated ICU environment.
Forward citations
Cited by 1 Pith paper
-
Beyond Prediction: Reinforcement Learning as the Defining Leap in Healthcare AI
A survey of reinforcement learning in healthcare that frames RL as a paradigm shift from prediction to agentive clinical intelligence.
Discussion (0). Sign in to comment.